Company Filing History:
1 out of 3 
1 out of 3 Years Active: 2008-2011
Title: **The Innovations of Sabina I Belli: A Leader in Biotechnology**
Introduction
Sabina I Belli, a prominent inventor based in Lane Cove, Australia, has made significant contributions to the field of biotechnology. With a total of two patents to her name, her work focuses on recombinant cloning, sequencing, and the development of vaccines against coccidiosis. Her innovative spirit and dedication to research have established her as a key figure in her field.
Latest Patents
Belli's latest patents revolve around the recombinant cloning and sequencing of two major gametocyte antigens, with molecular weights of 56 kDa and 82 kDa. These innovations enable the expression of these recombinant antigens using the plasmid pTrcHis. The patents also detail a vaccine against coccidiosis that incorporates the recombinant 56 kDa or 82 kDa antigen. Additionally, her work involves the identification of two 30 kDa proteins and three 14 kDa proteins from gametocytes, which could enhance the efficacy of the vaccine. The inventive methods described also provide immunization strategies against infections from microorganisms expressing immunologically cross-reactive antigens.
Career Highlights
Throughout her career, Belli has contributed to and worked within reputable companies such as Abic Biological Laboratories and Teva Ltd. These experiences have allowed her to advance her research and collaborate with other professionals in the biotechnology sector.
Collaborations
In her journey, Belli has had the opportunity to collaborate with notable coworkers, including Nicholas C. Smith and Michael Wallach. These partnerships have fostered a productive environment for innovation and the sharing of ideas, which are crucial to advancements in biotechnology.
Conclusion
Sabina I Belli's innovative contributions to the development of vaccines and her research in recombinant biotechnology demonstrate her commitment to improving health outcomes. Her work not only highlights the importance of collaboration in scientific endeavors but also emphasizes the transformative potential of her inventions in tackling diseases like coccidiosis. As she continues to innovate, Belli remains a vital asset to the field of biotechnology.